Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

FOCUS Clinical Drug Development

FOCUS’s Neuss Unit has performed &gt;600 Ph I-III studies, more than 80 first-in-man studies (NCE / NBE) and 38 Ph I studies in Japanese subjects since 1997.<br><br><br><br><br><br><br><br><br>

  • FOCUS Clinical Drug Development
  • FOCUS's Neuss Unit
  • Development candidates
  • FOCUS Immunology
  • FOCUS headquarters

Go Top